CoChat

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease

Open access
Cavedo, Enrica, for the Hippocampus Study Group, Dubois, Bruno, Colliot, Olivier, Lista, Simone, Croisile, Bernard, Tisserand, Guy Louis, Touchon, Jacques, Bonafe, Alain, Ousset, Pierre J., Rouaud, Olivier, Ricolfi, Fréderic, Vighetto, Alain, Pasquier, Florence, Galluzzi, Samantha, Delmaire, Christine, Ceccaldi, Mathieu, Girard, Nadine, Lehericy, Stéphane, Duveau, Françoise, Chupin, Marie, Sarazin, Marie, Dormont, Didier, Hampel, Harald · 2016 · The Journal of Clinical Psychiatry
Cited by 51

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Cortical thinning, previously identified during prodromal stages of Alzheimer's disease (AD), is a "candidate" biomarker implemented in AD clinical therapy trials. We investigated the effect of donepezil treatment on cortical thickness in mild cognitively impaired subjects with the amnestic syndrome of the hippocampal type, a prodromal at-risk group for progression to AD dementia. METHODS: Data were from a longitudinal analysis of a community-based multicenter suspected prodromal AD cohort diagnosed by the Free and Cued Selective Reminding Test (81 donepezil vs 92 placebo) enrolled in a double-blind, randomized, placebo-controlled parallel group design using donepezil (10 mg/day). The study started in November 2006 and concluded in August 2010. All subjects underwent 2 brain structural magnetic resonance imaging (MRI) scans, at baseline and at the end of the trial. Structural MRI images had been processed using the automated pipeline for longitudinal segmentation and surface reconstruction implemented in FreeSurfer. The primary outcome measure of this post hoc study was the annualized percentage change (APC) of cortical thickness. RESULTS: The donepezil group exhibited reduced APC cortical thinning compared to placebo in the rostral anterior cingulate (right: P = .048; left: P = .032), the orbitofrontal (right: P = .012; left: P < .048), and the right inferior frontal (P = .022) cortices and in the right insula (P = .010). These results were not statistically significant after Bonferroni correction likely due to insufficient power for cortical thickness measurements in the study group powered for the predefined hippocampus outcome. CONCLUSIONS: Our findings support the hypothesis that cortical thickness is a reliable candidate surrogate outcome in early predementia AD trials. In addition, donepezil treatment may have an impact on cortical structure/morphology in areas innervated by the medial and lateral cholinergic pathways. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00403520.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.15m10413

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 51

Metadata

Authors
Cavedo, E., for the Hippocampus Study Group, Dubois, B., Colliot, O., Lista, S., Croisile, B., Tisserand, G. L., Touchon, J., Bonafe, A., Ousset, P. J., Rouaud, O., Ricolfi, F., Vighetto, A., Pasquier, F., Galluzzi, S., Delmaire, C., Ceccaldi, M., Girard, N., Lehericy, S., Duveau, F., Chupin, M., Sarazin, M., Dormont, D., & Hampel, H.
Venue
The Journal of Clinical Psychiatry
Published
2016-10-25
Volume
77
Issue
12
Pages
e1631-e1638
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2532989070
Cited by
51
References
4
FWCI
4.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease. https://app.cochat.ai/papers/10.4088/jcp.15m10413
The paper
Cavedo, E., for the Hippocampus Study Group, Dubois, B., Colliot, O., Lista, S., Croisile, B., Tisserand, G. L., Touchon, J., Bonafe, A., Ousset, P. J., Rouaud, O., Ricolfi, F., Vighetto, A., Pasquier, F., Galluzzi, S., Delmaire, C., Ceccaldi, M., Girard, N., Lehericy, S., . . . Hampel, H. (2016). Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer’s Disease. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.15m10413

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.